CA2792950E — 5-(optionally substituted phenyl) pyridin-2-yl compounds as metalloenzyme inhibitors
Assigned to Mycovia Pharmaceuticals Inc · Expires 2011-10-27 · 15y expired
What this patent protects
The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes. The invention describes a compound of Formula (I), or salt thereof, wherein: (see formula I) MBG is…
USPTO Abstract
The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes. The invention describes a compound of Formula (I), or salt thereof, wherein: (see formula I) MBG is optionally substituted tetrazolyl, optionally substituted triazolyl, or optionally substituted pyrazolyl; R 1 is halo; R, is halo; each R 3 is independently alkyl, cyano, haloalkyl, alkoxy, halo, haloalkoxy, R4 is aryl optionally substituted with O, 1, 2 or 3 independent R3; R5 is H, or --C(O)alkyl optionally substituted with amino; n is 0, 1, 2 or 3.
Drugs covered by this patent
- Vivjoa (OTESECONAZOLE) · Mycovia Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.